You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 10, October 1995 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Articles
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Serum Antibodies to Heat Shock Protein 70 in Sensorineural Hearing Loss

Donald B. Bloch, MD; José E. San Martin, MD; Steven D. Rauch, MD; Richard A. Moscicki, MD; Kurt J. Bloch, MD

Arch Otolaryngol Head Neck Surg. 1995;121(10):1167-1171.


Abstract

Objective
To identify the 68-kd target of antibody in serum samples from patients with idiopathic, progressive, bilateral sensorineural hearing loss.

Design
To purify target protein from renal extracts using gel filtration, ion-exchange chromatography, and poly-acrylamide gel electrophoresis and to transfer to nitrocellulose membranes. The purified protein was digested with trypsin, and peptide fragments were separated by high-pressure liquid chromatography.

Results
One fraction obtained by high-performance liquid chromatography contained a peptide of 2776 molecular weight. The sequence of a stretch of 22 amino acids within this peptide was identical to that of amino acids 424 through 445 of heat shock protein 70 (HSP70). On Western blotting, monoclonal antibody directed against HSP70 (but capable of recognizing both constitutive HSP70 [HSC70] and stress-inducible HSP70) reacted with the purified 68-kd protein. We compared the reactivity of serum samples from six patients with idiopathic, progressive, bilateral sensorineural hearing loss, as well as monoclonal antibody to HSC70, and monoclonal antibody to HSP70 with renal extract. The pattern obtained suggested that patient antibodies are preferentially directed at HSP70.

Conclusion
The target of antibody in serum samples from patients with idiopathic, progressive, bilateral sensorineural hearing loss is HSP70.

(Arch Otolaryngol Head Neck Surg. 1995;121:1167-1171)



Author Affiliations

From the Departments of Medicine (Drs D. B. Bloch, Moscicki, and K. J. Bloch) and Otology and Laryngology (Drs San Martin and Rauch), Harvard Medical School; the Massachusetts Eye and Ear Infirmary (Drs San Martin and Rauch); and the Arthritis (Dr D. B. Bloch) and Clinical Immunology and Allergy (Drs Moscicki and K. J. Bloch) Units, General Medical Services, Massachusetts General Hospital, Boston.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased Frequencies of Cochlin-Specific T Cells in Patients with Autoimmune Sensorineural Hearing Loss
Baek et al.
J. Immunol. 2006;177:4203-4210.
ABSTRACT | FULL TEXT  

Corticosteroid Response and Supporting Cell Antibody in Autoimmune Hearing Loss
Zeitoun et al.
Arch Otolaryngol Head Neck Surg 2005;131:665-672.
ABSTRACT | FULL TEXT  

Systemic autoantibodies against discrete inner ear compartments in bilateral vestibular loss
Agrup et al.
Neurology 2005;65:167-167.
FULL TEXT  

Identification and Characterization of Choline Transporter-Like Protein 2, an Inner Ear Glycoprotein of 68 and 72 kDa That Is the Target of Antibody-Induced Hearing Loss
Nair et al.
J. Neurosci. 2004;24:1772-1779.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.